Clinical Trial

A Study of HRS9531 Injection in Obese Subjects With Obstructive Sleep Apnea

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the effect and safety of HRS9531 Injection in Obese Subjects with Obstructive Sleep Apnea
Trial Details
NCT Number NCT06565871
Lead Sponsor Fujian Shengdi Pharmaceutical Co., Ltd.
Conditions Weight Management
Enrollment 108 participants
Start Date 2024-08
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-08-22